Gaëtan Billioud

Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure

Stéphanie Villet, Christian Pichoud, Gaëtan Billioud et al. · Journal of Hepatology · 2008 · 186 citations

Life Sciences, Infectious Diseases, Molecular Biology +9

The main Hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication

Gaëtan Billioud, Christian Pichoud, Gerhard Puerstinger et al. · Antiviral Research · 2011 · 78 citations

Life Sciences, Infectious Diseases, Molecular Biology +16

In Vitro Characterization of Viral Fitness of Therapy-Resistant Hepatitis B Variants

Stéphanie Villet, Gaëtan Billioud, Christian Pichoud et al. · Gastroenterology · 2008 · 68 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +15

In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides

Gaëtan Billioud, Robert L. Kruse, Melissa Carrillo et al. · Journal of Hepatology · 2015 · 55 citations

Life Sciences, Infectious Diseases, Molecular Biology +14

Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus–Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses

Kelong Han, Dickens Theodore, Gina McMullen et al. · Clinical Pharmacology in Drug Development · 2022 · 16 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17